Reaction Details | |||
---|---|---|---|
Report a problem with these data | |||
Target | Oxysterols receptor LXR-beta | ||
Ligand | BDBM115077 | ||
Substrate/Competitor | n/a | ||
Meas. Tech. | Counterscreen for agonists of the daf-12 abnormal Dauer Formation: Luminescence-based cell-based dose response screening assay to identify agonists of the Liver-X-Receptor (LXR) | ||
EC50 | 67595±n/a nM | ||
Citation | PubChem, PC Counterscreen for agonists of the daf-12 abnormal Dauer Formation: Luminescence-based cell-based dose response screening assay to identify agonists of the Liver-X-Receptor (LXR) PubChem Bioassay(2013)[AID] | ||
More Info.: | Get all data from this article, Solution Info, Assay Method | ||
Oxysterols receptor LXR-beta | |||
Name: | Oxysterols receptor LXR-beta | ||
Synonyms: | LXRB | Liver X receptor beta (NR1H2) | Liver X, LXR beta | NER | NR1H2 | NR1H2_HUMAN | Nuclear receptor NER | UNR | Ubiquitously-expressed nuclear receptor | ||
Type: | Enzyme Catalytic Domain | ||
Mol. Mass.: | 50978.79 | ||
Organism: | Homo sapiens (Human) | ||
Description: | P55055 | ||
Residue: | 460 | ||
Sequence: |
| ||
BDBM115077 | |||
n/a | |||
Name | BDBM115077 | ||
Synonyms: | 1-methyl-N-(4-methylcyclohexyl)-2-pyrrolecarboxamide | 1-methyl-N-(4-methylcyclohexyl)pyrrole-2-carboxamide | MLS002180256 | SMR001269286 | cid_25161651 | ||
Type | Small organic molecule | ||
Emp. Form. | C13H20N2O | ||
Mol. Mass. | 220.3107 | ||
SMILES | CC1CCC(CC1)NC(=O)c1cccn1C |(4.46,-5.42,;4.46,-3.88,;5.79,-3.11,;5.79,-1.57,;4.46,-.8,;3.12,-1.57,;3.12,-3.11,;4.46,.74,;5.79,1.51,;7.12,.74,;5.79,3.05,;7.04,3.96,;6.56,5.42,;5.02,5.42,;4.54,3.96,;3.08,3.48,)| | ||
Structure |